Case for continuing community NIV and CPAP during the COVID-19 epidemic
- PMID: 32273336
- DOI: 10.1136/thoraxjnl-2020-214913
Case for continuing community NIV and CPAP during the COVID-19 epidemic
Keywords: assisted ventilation; critical care; non invasive ventilation; sleep apnoea.
Conflict of interest statement
Competing interests: JGB provides molecular pharmacology advice for CuraSen Therapeutics. MS has received speaking fees from Chiesi, StraZeneca and Radiometer, received assistance form ResMed towards attending ERS, received funding from RESMED, Breas and Philips Respironics towards organising a Sleep and Ventilation course and received a £45,000 Research Grant and four Transcutaneous carbon dioxide monitors (TCM5) as well as consumables from Radiometer towards a multicentre study.
Comment on
-
COVID-19: community CPAP and NIV should be stopped unless medically necessary to support life.Thorax. 2020 May;75(5):367. doi: 10.1136/thoraxjnl-2020-214890. Epub 2020 Apr 9. Thorax. 2020. PMID: 32273335 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources